https://news.medxy.ai/zh/early-pregnancy-insulin-effects/Medxy AIzh2026-11-09T08:42:10-08:00妊娠早期胰岛素敏感性与分泌功能对新生儿结局及产后血糖调控的不同影响 https://news.medxy.ai/ja/early-pregnancy-insulin-effects/Medxy AIja2026-11-09T08:41:50-08:00妊娠初期のインスリン感受性と分泌能が新生児転帰と産後血糖調節に及ぼす異なる影響 https://news.medxy.ai/vi/early-pregnancy-insulin-disorders/Medxy AIvi2026-11-09T08:41:31-08:00Kháng insulin sớm và rối loạn tiết insulin trong thai kỳ: tác động khác nhau lên kết cục sơ sinh và điều hòa glucose sau sinh https://news.medxy.ai/zh/ez-pave-trial-insights/Medxy AIzh2026-11-09T08:40:22-08:00ASCVD中他汀-依折麦布联合治疗优于单药降脂吗？——Ez-PAVE试验揭示的启示 https://news.medxy.ai/ja/statin-ezetimibe-combination-therapy/Medxy AIja2026-11-09T08:39:59-08:00ASCVDにおけるスタチン・エゼチミブ併用療法は単剤療法を上回るか：Ez-PAVE試験からの知見 https://news.medxy.ai/vi/93864-2/Medxy AIvi2026-11-09T08:39:37-08:00 https://news.medxy.ai/zh/graft-choice-outcomes/Medxy AIzh2026-11-09T08:38:27-08:00ACL-MCL联合损伤中移植物选择对预后的影响：来自法国多中心登记研究的启示 https://news.medxy.ai/ja/graft-choice-outcomes/Medxy AIja2026-11-09T08:37:56-08:00ACL-MCL複合損傷における移植片選択は転帰にどう影響するか：フランス多施設レジストリ研究からの知見 https://news.medxy.ai/vi/acl-graft-choice-outcomes/Medxy AIvi2026-11-09T08:37:32-08:00Ảnh hưởng của lựa chọn mảnh ghép ACL đến kết cục trong tổn thương phối hợp ACL-MCL: Gợi ý từ một cơ sở đăng ký đa trung tâm của Pháp https://news.medxy.ai/zh/balance-sensory-dysfunction-inph/Medxy AIzh2026-11-09T08:36:27-08:00特发性正常压力脑积水中的平衡受损与感觉功能障碍：来自感觉组织测试的启示 https://news.medxy.ai/ja/93857-2/Medxy AIja2026-11-09T08:36:08-08:00 https://news.medxy.ai/vi/balance-sensory-disorders/Medxy AIvi2026-11-09T08:35:32-08:00Suy giảm thăng bằng và rối loạn cảm giác trong não úng thủy áp lực bình thường vô căn: Góc nhìn từ Bài kiểm tra Tổ chức Cảm giác https://news.medxy.ai/ja/93854-2/Medxy AIja2026-11-09T08:34:24-08:00 https://news.medxy.ai/vi/toothpaste-effects-dentin-radiotherapy/Medxy AIvi2026-11-09T08:33:59-08:00Ảnh hưởng của các công thức kem đánh răng khác nhau lên độ vi cứng bề mặt và hoạt tính phân giải gelatin ở ngà răng khỏe mạnh và ngà răng sau xạ trị: Nghiên cứu in vitro https://news.medxy.ai/zh/minor-stroke-large-vessel-occlusion/Medxy AIzh2026-11-09T08:32:55-08:00轻型卒中合并大血管闭塞：急性缺血性卒中管理的新范式 https://news.medxy.ai/ja/advances-in-endovascular-stroke-treatment/Medxy AIja2026-11-09T08:32:35-08:00軽症脳卒中に対する血管内治療の新展開：大血管閉塞を伴う急性期虚血性脳卒中管理の転換点 https://news.medxy.ai/vi/endovascular-treatment-breakthrough/Medxy AIvi2026-11-09T08:32:12-08:00Đột phá điều trị nội mạch ở đột quỵ nhẹ có tắc mạch máu lớn: Bước ngoặt trong xử trí đột quỵ thiếu máu cục bộ cấp https://news.medxy.ai/zh/upper-limb-use-after-stroke/Medxy AIzh2026-11-08T19:52:33-08:00卒中亚急性期上肢使用动态：来自真实生活与临床情境加速度测量的启示 https://news.medxy.ai/ja/upper-limb-use-after-stroke/Medxy AIja2026-11-08T19:52:13-08:00亜急性期脳卒中における上肢使用の変化：実生活と臨床場面を捉えた加速度計測からの示唆 https://news.medxy.ai/vi/upper-limb-use-kinematics/Medxy AIvi2026-11-08T19:51:54-08:00Động học sử dụng chi trên trong giai đoạn bán cấp sau đột quỵ: Bằng chứng từ đo gia tốc trong thực tế và môi trường lâm sàng https://news.medxy.ai/zh/in-office-teeth-whitening/Medxy AIzh2026-11-08T19:50:47-08:00诊室牙齿漂白可更快完成：酸性 pH 凝胶缩短治疗间隔的安全性与疗效 https://news.medxy.ai/ja/faster-safer-teeth-whitening/Medxy AIja2026-11-08T19:50:25-08:00オフィス内歯牙漂白をより速く、安全に：酸性ゲルによる短縮間隔プロトコルの有効性と安全性 https://news.medxy.ai/vi/faster-clinic-teeth-whitening/Medxy AIvi2026-11-08T19:50:04-08:00Tẩy trắng răng tại phòng khám nhanh hơn: Tính an toàn và hiệu quả của việc rút ngắn khoảng cách điều trị với gel pH acid https://news.medxy.ai/zh/first-line-endometrial-cancer-advances/Medxy AIzh2026-11-08T19:48:47-08:00dMMR晚期或复发性子宫内膜癌的一线治疗新进展：KEYNOTE-C93 III期试验解读 https://news.medxy.ai/ja/pembrolizumab-endometrial-cancer/Medxy AIja2026-11-08T19:48:25-08:00dMMR進行・再発子宮内膜がんの一次治療におけるペムブロリズマブ：KEYNOTE-C93第3相試験から見えたこと https://news.medxy.ai/vi/pembrolizumab-endometrial-cancer/Medxy AIvi2026-11-08T19:48:07-08:00Pembrolizumab làm điều trị hàng đầu cho ung thư nội mạc tử cung dMMR tiến triển hoặc tái phát: Góc nhìn từ thử nghiệm pha 3 KEYNOTE-C93 https://news.medxy.ai/ja/pediatric-penicillin-delabeling/Medxy AIja2026-11-08T19:47:07-08:00儿童青霉素过敏去标签：2026年《Pediatrics》指导的核心建议 https://news.medxy.ai/vi/remove-penicillin-allergy-labels/Medxy AIvi2026-11-08T19:46:39-08:00Tháo bỏ nhãn dị ứng penicillin ở trẻ em: Những khuyến nghị quan trọng từ hướng dẫn Pediatrics 2026 https://news.medxy.ai/zh/pediatric-penicillin-delabeling-guidelines/Medxy AIzh2026-11-08T19:46:07-08:00儿童青霉素过敏去标签新指南：2026年《Pediatrics》关键建议 https://news.medxy.ai/zh/rheumatoid-arthritis-ultrasound-assessment/Medxy AIzh2026-11-08T19:44:44-08:00类风湿关节炎评估新进展：Global OMERACT超声关节损伤评分系统（GLODS） https://news.medxy.ai/ja/rheumatoid-arthritis-assessment/Medxy AIja2026-11-08T19:44:22-08:00関節リウマチ評価を前進させる：Global OMERACT超音波関節損傷スコアリングシステム（GLODS） https://news.medxy.ai/vi/rheumatoid-arthritis-ultrasound-score/Medxy AIvi2026-11-08T19:44:01-08:00Nâng cao đánh giá viêm khớp dạng thấp: Hệ thống Chấm điểm Tổn thương Khớp bằng Siêu âm OMERACT Toàn cầu (GLODS) https://news.medxy.ai/zh/endothelial-hla-f-kidney-rejection/Medxy AIzh2026-11-08T19:43:03-08:00肾移植抗体介导性排斥反应中的内皮HLA-F：来自空间转录组学的预后新线索 https://news.medxy.ai/ja/93795-2/Medxy AIja2026-11-08T19:42:40-08:00 https://news.medxy.ai/vi/endothelial-hla-f-antibody-mediated-rejection/Medxy AIvi2026-11-08T19:42:17-08:00HLA-F nội mô: dấu ấn tiên lượng mới trong thải ghép qua trung gian kháng thể ở ghép thận https://news.medxy.ai/zh/mucous-pemphigoid-treatment-patterns/Medxy AIzh2026-11-08T19:41:12-08:00多部位黏膜类天疱疮的按部位治疗与缓解模式：一项综合综述 https://news.medxy.ai/ja/mucous-membrane-pemphigoid-review/Medxy AIja2026-11-08T19:40:50-08:00多部位粘膜類天疱瘡における部位別治療と寛解パターン：包括的レビュー https://news.medxy.ai/vi/93790-2/Medxy AIvi2026-11-08T19:40:28-08:00 https://news.medxy.ai/zh/app-led-body-contouring-clinic/Medxy AIzh2026-11-08T18:47:02-08:00APP主导体型塑形门诊：提升可及性与手术转化的高效路径 https://news.medxy.ai/ja/body-contouring-accessibility/Medxy AIja2026-11-08T18:46:45-08:00体型雕塑中的“放大效应”：借助高级实践提供者门诊提升可及性与手术转化率 https://news.medxy.ai/vi/93786-2/Medxy AIvi2026-11-08T18:46:26-08:00 https://news.medxy.ai/ja/icu-recovery-education-curriculum/Medxy AIja2026-11-08T18:45:16-08:00ICU回復教育カリキュラムの構築：国際 Delphi が示した臨床家向け重点学習モジュール https://news.medxy.ai/vi/icu-rehabilitation-curriculum/Medxy AIvi2026-11-08T18:44:51-08:00Xây dựng chương trình học phục hồi ICU: Đồng thuận Delphi quốc tế xác định các mô-đun ưu tiên cho bác sĩ lâm sàng https://news.medxy.ai/zh/icu-rehabilitation-curriculum/Medxy AIzh2026-11-08T18:44:28-08:00构建ICU康复课程：国际Delphi研究确定临床医生优先学习模块 https://news.medxy.ai/zh/real-time-delayed-video-assessment/Medxy AIzh2026-11-08T18:43:03-08:00实时与延迟视频 TEAM 评估谁更准？成人心搏骤停复苏中的一致性与评估者经验解析 https://news.medxy.ai/ja/live-vs-video-assessment/Medxy AIja2026-11-08T18:42:46-08:00実臨床の心停止でライブ評価と遅延ビデオ評価はどこまで一致するのか：TEAM評価の信頼性と評価者経験を検討 https://news.medxy.ai/vi/team-video-assessment/Medxy AIvi2026-11-08T18:42:28-08:00Đánh giá TEAM qua video: Trực tiếp hay trì hoãn trong hồi sức ngừng tim thực tế? https://news.medxy.ai/zh/kit-d816v-inhibitor-aml-risk/Medxy AIzh2026-11-08T18:40:55-08:00KIT D816V选择性酪氨酸激酶抑制剂可显著降低伴髓系肿瘤的系统性肥大细胞增多症患者AML转化风险 https://news.medxy.ai/ja/kit-d816v-tki-reduces-aml-risk/Medxy AIja2026-11-08T18:40:40-08:00KIT D816V選択的TKIがSM-AHNのAML移行リスクを有意に低下 https://news.medxy.ai/vi/tki-reduces-aml-progression-risk/Medxy AIvi2026-11-08T18:40:20-08:00TKI làm giảm rõ rệt nguy cơ chuyển dạng AML ở tăng sinh dưỡng bào hệ thống kèm bệnh lý tân sinh dòng tủy https://news.medxy.ai/zh/primary-graft-dysfunction-lung-transplant/Medxy AIzh2026-11-08T18:39:32-08:00原发性移植物功能障碍对肺移植长期移植物功能及慢性肺移植物功能障碍的影响：来自 Lung Transplant Outcomes Group 队列的研究洞见 https://news.medxy.ai/ja/primary-graft-dysfunction-long-term-outcomes/Medxy AIja2026-11-08T18:39:14-08:00一次移植片機能不全は長期肺移植片機能にどう影響するか：Lung Transplant Outcomes GroupコホートからみたCLADとの関係 https://news.medxy.ai/vi/primary-graft-dysfunction-long-term-outcomes/Medxy AIvi2026-11-08T18:38:57-08:00Ảnh hưởng của rối loạn chức năng mảnh ghép nguyên phát đến chức năng mảnh ghép phổi dài hạn và rối loạn chức năng mảnh ghép phổi mạn tính: Những phát hiện từ đoàn hệ Lung Transplant Outcomes Group https://news.medxy.ai/zh/93767-2/Medxy AIzh2026-11-08T18:38:05-08:00 https://news.medxy.ai/ja/93766-2/Medxy AIja2026-11-08T18:37:48-08:00 https://news.medxy.ai/vi/central-serous-chorioretinopathy-genetics/Medxy AIvi2026-11-08T18:37:23-08:00Giải mã nền tảng di truyền của bệnh lý trung tâm thanh dịch võng mạc hắc mạc: Hàm ý cho cơ chế bệnh sinh và y học chính xác https://news.medxy.ai/zh/nasopharyngeal-cancer-reconstruction/Medxy AIzh2026-11-08T18:36:25-08:00鼻咽癌放疗后颅底骨放射性坏死：带血管蒂皮瓣重建的长期疗效 https://news.medxy.ai/ja/long-term-flap-reconstruction-outcomes/Medxy AIja2026-11-08T18:36:09-08:00鼻咽頭癌放射線治療後の頭蓋底骨放射線性壊死に対する血管柄付き皮弁再建の長期成績 https://news.medxy.ai/vi/long-term-skull-base-reconstruction/Medxy AIvi2026-11-08T18:35:51-08:00Kết quả dài hạn của tái tạo bằng vạt có mạch nuôi trong hoại tử xương do tia xạ nền sọ sau xạ trị ung thư biểu mô vòm họng https://news.medxy.ai/zh/gender-differences-in-hernia-repair/Medxy AIzh2026-11-08T18:34:57-08:00腹壁疝修补术结局中的性别差异：一项长达十年的队列研究发现 https://news.medxy.ai/ja/93758-2/Medxy AIja2026-11-08T18:34:38-08:00 https://news.medxy.ai/vi/93757-2/Medxy AIvi2026-11-08T18:34:18-08:00 https://news.medxy.ai/zh/uterine-sarcoma-disparities/Medxy AIzh2026-11-08T18:33:16-08:00剖析子宫肉瘤：美国不同组织学亚型与种族的年龄别发病及生存差异（2000—2019年） https://news.medxy.ai/ja/93754-2/Medxy AIja2026-11-08T18:32:54-08:00 https://news.medxy.ai/vi/uterine-sarcoma-epidemiology/Medxy AIvi2026-11-08T18:32:36-08:00Sarcoma tử cung dưới góc nhìn dịch tễ: khác biệt theo tuổi, kiểu mô học và chủng tộc trong giai đoạn 2000–2019 tại Hoa Kỳ https://news.medxy.ai/zh/imaging-biomarkers-tumor-heterogeneity/Medxy AIzh2026-11-08T18:31:44-08:00借助影像生物标志物解析肿瘤异质性：预测接受 TACE-ICI-MTT 治疗的肝细胞癌患者疗效与生存 https://news.medxy.ai/ja/imaging-biomarkers-hcc-treatment-response/Medxy AIja2026-11-08T18:31:24-08:00画像バイオマーカーで解く腫瘍不均一性──TACE・ICI・分子標的治療を受けるHCCの治療反応と生存予測 https://news.medxy.ai/vi/decoding-tumor-heterogeneity/Medxy AIvi2026-11-08T18:31:03-08:00Giải mã tính không đồng nhất của khối u bằng dấu ấn hình ảnh để dự đoán đáp ứng và sống còn trong HCC điều trị bằng TACE-ICI-MTT https://news.medxy.ai/zh/93747-2/Medxy AIzh2026-11-08T18:30:06-08:00 https://news.medxy.ai/ja/early-rhythm-control-after-stroke/Medxy AIja2026-11-08T18:29:40-08:00急性虚血性脳卒中後の心房細動に対する早期リズムコントロール：包括的臨床レビュー https://news.medxy.ai/vi/93745-2/Medxy AIvi2026-11-08T18:29:21-08:00 https://news.medxy.ai/zh/inflammation-after-repeat-bariatric-surgery/Medxy AIzh2026-11-08T18:28:08-08:00重复减重手术后皮下脂肪的炎症变化：女性体重反弹的机制线索 https://news.medxy.ai/ja/inflammatory-changes-after-bariatric-surgery/Medxy AIja2026-11-08T18:27:52-08:00反復バリアトリック手術後の皮下脂肪にみられる炎症性変化：女性の体重再増加を読み解く鍵 https://news.medxy.ai/vi/subcutaneous-fat-inflammation-after-bariatric-surgery/Medxy AIvi2026-11-08T18:27:33-08:00Viêm mô mỡ dưới da sau phẫu thuật bariatric lặp lại: góc nhìn về tăng cân trở lại ở phụ nữ https://news.medxy.ai/zh/iv-iron-hfpef-exercise-tolerance/Medxy AIzh2026-11-08T18:26:38-08:00静脉补铁能否改善HFpEF患者运动耐量？——IRONMET-HFpEF试验带来的启示 https://news.medxy.ai/ja/93738-2/Medxy AIja2026-11-08T18:26:23-08:00 https://news.medxy.ai/vi/93737-2/Medxy AIvi2026-11-08T18:26:06-08:00 https://news.medxy.ai/zh/forearm-strain-elbow-surgery-risk/Medxy AIzh2026-11-08T18:25:09-08:00前臂屈肌拉伤能否预测 MLB 投手尺侧副韧带手术风险？——一项匹配生存分析 https://news.medxy.ai/ja/93734-2/Medxy AIja2026-11-08T18:24:52-08:00 https://news.medxy.ai/vi/93733-2/Medxy AIvi2026-11-08T18:24:36-08:00 https://news.medxy.ai/zh/post-stroke-dysphagia-tube-feeding/Medxy AIzh2026-11-08T18:23:25-08:00卒中后吞咽障碍：间歇性口食管管饲较鼻胃管喂养更具临床优势的随机试验 https://news.medxy.ai/ja/post-stroke-feeding-comparison/Medxy AIja2026-11-08T18:23:04-08:00脳卒中後嚥下障害における間欠的口食道経管栄養と経鼻胃管栄養の比較：無作為化試験が示した臨床的利点 https://news.medxy.ai/vi/intermittent-feeding-stroke-swallowing/Medxy AIvi2026-11-08T18:22:37-08:00Nuôi ăn ngắt quãng qua ống miệng-thực quản hay ống thông mũi-dạ dày ở loạn dưỡng nuốt sau đột quỵ: thử nghiệm ngẫu nhiên cho thấy lợi ích lâm sàng nổi bật https://news.medxy.ai/zh/dynamic-guided-preparation/Medxy AIzh2026-11-08T18:21:47-08:00动态导航能否提升 socket-shield technique 的精准度与信心：初学牙医徒手与引导式预备的比较 https://news.medxy.ai/ja/socket-shield-technique-training/Medxy AIja2026-11-08T18:21:32-08:00初心者歯科医師におけるSocket-Shield Techniqueの精度と自信を高める：Dynamic Navigation と Freehand 形成の比較 https://news.medxy.ai/vi/93725-2/Medxy AIvi2026-11-08T18:21:15-08:00 https://news.medxy.ai/zh/anbenitamab-her2-breast-cancer/Medxy AIzh2026-11-08T18:20:01-08:00安贝尼单抗联合 HB1801 为 HER2 阳性晚期乳腺癌带来新希望：Ⅲ期研究结果 https://news.medxy.ai/ja/promising-her2-breast-cancer-therapy/Medxy AIja2026-11-08T18:19:46-08:00HER2陽性進行乳癌でanbenitamab＋HB1801が有望な効果を示す：第3相試験 https://news.medxy.ai/vi/anbenitamab-her2-breast-cancer/Medxy AIvi2026-11-08T18:19:27-08:00Anbenitamab phối hợp HB1801 cho thấy hiệu quả đầy hứa hẹn ở ung thư vú tiến triển dương tính HER2: thử nghiệm pha 3 https://news.medxy.ai/zh/high-intensity-walking-training/Medxy AIzh2026-11-08T09:12:32-08:00高强度步行训练如何促进慢性卒中步行恢复：对侧皮质-网状脊髓束变化的作用 https://news.medxy.ai/ja/enhancing-chronic-stroke-walking-recovery/Medxy AIja2026-11-08T09:12:10-08:00慢性期脳卒中の歩行回復を高めるには：高強度歩行訓練後の対側大脳皮質—網様体—脊髄路変化の役割 https://news.medxy.ai/vi/walking-recovery-stroke-rehabilitation/Medxy AIvi2026-11-08T09:11:43-08:00Phục hồi khả năng đi lại trong đột quỵ mạn tính: vai trò của những thay đổi ở bó vỏ não–lưới–tủy sống bên đối diện tổn thương sau tập luyện vận động cường độ cao https://news.medxy.ai/enhancing-walking-recovery-in-chronic-stroke-the-role-of-contralesional-cortico-reticulospinal-tract-changes-following-high-intensity-locomotor-training/Medxy AIen2026-11-08T09:11:23-08:00Enhancing Walking Recovery in Chronic Stroke: The Role of Contralesional Cortico-Reticulospinal Tract Changes Following High-Intensity Locomotor Training https://news.medxy.ai/zh/ai-vs-clinicians-periodontal-tooth-loss-prediction/Medxy AIzh2026-11-08T09:10:38-08:00AI与临床医生谁更准：10年牙周牙齿脱失预后预测的准确性对比 https://news.medxy.ai/ja/ai-vs-clinicians-periodontal-tooth-loss/Medxy AIja2026-11-08T09:10:20-08:00AIと臨床医、どちらがより正確か：歯周病による歯の喪失に関する10年後の予後予測精度の比較 https://news.medxy.ai/vi/ai-vs-clinicians-periodontal-tooth-loss-prediction-2/Medxy AIvi2026-11-08T09:09:59-08:00AI so với bác sĩ lâm sàng: Độ chính xác tiên lượng mất răng nha chu sau 10 năm https://news.medxy.ai/ai-versus-clinicians-evaluating-accuracy-in-10-year-periodontal-tooth-loss-prognosis/Medxy AIen2026-11-08T09:09:42-08:00AI Versus Clinicians: Evaluating Accuracy in 10-Year Periodontal Tooth Loss Prognosis https://news.medxy.ai/zh/endometrial-ablation-levonorgestrel-intrauterine-system/Medxy AIzh2026-11-08T09:08:58-08:00子宫内膜消融联合左炔诺孕酮宫内系统：降低重度月经过多患者子宫切除率的新证据 https://news.medxy.ai/ja/endometrial-ablation-lng-ius/Medxy AIja2026-11-08T09:08:40-08:00過多月経に対する子宮内膜焼灼術とLNG-IUS併用：MIRA2試験が示す子宮摘出術減少の可能性 https://news.medxy.ai/vi/endometrial-ablation-lng-ius-menorrhagia/Medxy AIvi2026-11-08T09:08:19-08:00Đốt nội mạc tử cung phối hợp LNG-IUS: giảm nhu cầu cắt tử cung ở rong kinh nhiều từ thử nghiệm MIRA2 https://news.medxy.ai/combining-endometrial-ablation-with-levonorgestrel-ius-to-reduce-hysterectomy-in-heavy-menstrual-bleeding-insights-from-the-mira2-trial/Medxy AIen2026-11-08T09:08:02-08:00Combining Endometrial Ablation with Levonorgestrel IUS to Reduce Hysterectomy in Heavy Menstrual Bleeding: Insights from the MIRA2 Trial https://news.medxy.ai/zh/pediatric-antibiotic-stewardship/Medxy AIzh2026-11-08T09:07:23-08:00优化儿科急诊肺炎与鼻窦炎抗生素疗程：一项质量改进的成功实践 https://news.medxy.ai/ja/pediatric-antibiotic-stewardship-for-sinusitis/Medxy AIja2026-11-08T09:07:05-08:00小児救急における肺炎および副鼻腔炎に対する抗菌薬投与期間の最適化：質改善の成功事例 https://news.medxy.ai/vi/shorter-antibiotics-for-children/Medxy AIvi2026-11-08T09:06:42-08:00Rút ngắn thời gian dùng kháng sinh cho viêm phổi và viêm xoang ở trẻ em tại khoa cấp cứu: Thành công từ một chương trình cải tiến chất lượng https://news.medxy.ai/optimizing-antibiotic-duration-for-pediatric-pneumonia-and-sinusitis-in-the-emergency-department-a-quality-improvement-success/Medxy AIen2026-11-08T09:06:25-08:00Optimizing Antibiotic Duration for Pediatric Pneumonia and Sinusitis in the Emergency Department: A Quality Improvement Success https://news.medxy.ai/zh/refractory-psoriatic-arthritis/Medxy AIzh2026-11-08T09:05:43-08:00北欧生物制剂治疗银屑病关节炎患者中难治管理与治疗难治性疾病的患病率及特征 https://news.medxy.ai/ja/treatment-resistant-psa-in-nordic-patients/Medxy AIja2026-11-08T09:05:26-08:00北欧PsA患者における治療困難例と治療抵抗性例の有病率・特徴 https://news.medxy.ai/vi/psoriatic-arthritis-biologic-resistance/Medxy AIvi2026-11-08T09:05:06-08:00Viêm khớp vảy nến khó kiểm soát và kháng trị ở bệnh nhân Bắc Âu điều trị bằng thuốc sinh học https://news.medxy.ai/prevalence-and-profile-of-difficult-to-manage-and-treatment-refractory-psoriatic-arthritis-in-nordic-patients-on-biologic-therapies/Medxy AIen2026-11-08T09:04:48-08:00Prevalence and Profile of Difficult-to-Manage and Treatment-Refractory Psoriatic Arthritis in Nordic Patients on Biologic Therapies https://news.medxy.ai/zh/lung-transplant-support-strategies/Medxy AIzh2026-11-08T09:04:12-08:00肺移植术中支持策略优化：限制性体外循环与基于标准的ECMO对早期神经结局的影响 https://news.medxy.ai/ja/lung-transplant-support-ecmo/Medxy AIja2026-11-08T09:03:57-08:00肺移植術中サポート戦略の最適化：制限的体外循環および基準に基づくECMOが早期神経学的転帰に及ぼす影響 https://news.medxy.ai/vi/lung-transplant-support/Medxy AIvi2026-11-08T09:03:38-08:00Tối ưu hóa hỗ trợ trong mổ khi ghép phổi: Ảnh hưởng của CPB hạn chế so với ECMO dựa trên tiêu chí đối với kết cục thần kinh sớm https://news.medxy.ai/optimizing-intraoperative-support-in-lung-transplantation-impact-of-restrictive-cpb-versus-criteria-based-ecmo-on-early-neurologic-outcomes/Medxy AIen2026-11-08T09:03:21-08:00Optimizing Intraoperative Support in Lung Transplantation: Impact of Restrictive CPB Versus Criteria-Based ECMO on Early Neurologic Outcomes https://news.medxy.ai/zh/dupilumab-improves-growth-bone-health/Medxy AIzh2026-11-08T09:02:40-08:00Dupilumab 促进重症特应性皮炎患儿生长并改善骨健康：来自 3 期试验的研究发现 https://news.medxy.ai/ja/dupilumab-improves-growth-bone-health-in-children/Medxy AIja2026-11-08T09:02:21-08:00デュピルマブは重症アトピー性皮膚炎の小児の成長を促進し、骨の健康を改善する：第3相試験からの知見 https://news.medxy.ai/vi/dupilumab-improves-growth-bone-health-2/Medxy AIvi2026-11-08T09:01:57-08:00Dupilumab giúp cải thiện tăng trưởng và sức khỏe xương ở trẻ em mắc viêm da cơ địa nặng: Kết quả từ thử nghiệm pha 3 https://news.medxy.ai/dupilumab-enhances-growth-and-bone-health-in-pediatric-severe-atopic-dermatitis-insights-from-a-phase-3-trial/Medxy AIen2026-11-08T09:01:38-08:00Dupilumab Enhances Growth and Bone Health in Pediatric Severe Atopic Dermatitis: Insights from a Phase 3 Trial https://news.medxy.ai/zh/beyond-bmi-risk-stratification/Medxy AIzh2026-11-08T09:00:58-08:00超越BMI：DIEP皮瓣乳房重建的风险分层应关注皮下脂肪组织与吸烟史 https://news.medxy.ai/ja/diep-flap-risk-stratification/Medxy AIja2026-11-08T09:00:35-08:00DIEPフラップ乳房再建のリスク層別化を見直す：BMIを超えて重要となる皮下脂肪組織と喫煙歴 https://news.medxy.ai/vi/diep-flap-risk-stratification-2/Medxy AIvi2026-11-08T09:00:06-08:00Tinh chỉnh phân tầng nguy cơ trong tái tạo vú bằng vạt DIEP: Vai trò của mô mỡ dưới da và tiền sử hút thuốc vượt lên trên BMI https://news.medxy.ai/refining-risk-stratification-in-diep-flap-breast-reconstruction-the-role-of-subcutaneous-adipose-tissue-and-smoking-history-beyond-bmi/Medxy AIen2026-11-08T08:59:46-08:00Refining Risk Stratification in DIEP Flap Breast Reconstruction: The Role of Subcutaneous Adipose Tissue and Smoking History Beyond BMI https://news.medxy.ai/zh/sepsis-after-organ-transplantation/Medxy AIzh2026-11-08T08:59:07-08:00腹部实体器官移植受者脓毒症的独特免疫谱与生存获益：一项多中心前瞻性队列研究 https://news.medxy.ai/ja/improved-sepsis-outcomes-transplant-patients/Medxy AIja2026-11-08T08:58:45-08:00腹部固形臓器移植患者の敗血症転帰はなぜ良好なのか――多施設前向きコホート研究が示す特異的免疫プロファイルと生存改善 https://news.medxy.ai/vi/abdominal-transplant-sepsis-immunity-survival/Medxy AIvi2026-11-08T08:58:23-08:00Ghép tạng đặc rắn ổ bụng và sepsis: kiểu hình miễn dịch khác biệt cùng cải thiện sống còn qua nghiên cứu đoàn hệ tiền cứu đa trung tâm https://news.medxy.ai/distinct-immunological-profiles-and-improved-survival-in-sepsis-among-abdominal-solid-organ-transplant-recipients-insights-from-a-multicenter-prospective-cohort-study/Medxy AIen2026-11-08T08:58:03-08:00Distinct Immunological Profiles and Improved Survival in Sepsis among Abdominal Solid Organ Transplant Recipients: Insights from a Multicenter Prospective Cohort Study https://news.medxy.ai/zh/ambient-ai-emergency-documentation/Medxy AIzh2026-11-08T08:57:19-08:00环境式AI与人工文书员对急诊医师文书负担和临床生产力的影响：最新证据综述 https://news.medxy.ai/ja/medical-scribe-ai-review/Medxy AIja2026-11-08T08:57:01-08:00救急医の文書作成負担を減らすのは誰か：medical scribe と ambient AI の最新エビデンスレビュー https://news.medxy.ai/medical-scribe-and-ambient-artificial-intelligence-impact-on-emergency-physician-documentation-burden-and-clinical-productivity-a-contemporary-evidence-review/Medxy AIen2026-11-08T08:56:14-08:00Medical Scribe and Ambient Artificial Intelligence Impact on Emergency Physician Documentation Burden and Clinical Productivity: A Contemporary Evidence Review https://news.medxy.ai/zh/high-risk-chronic-care/Medxy AIzh2026-11-08T08:55:27-08:00高风险患者慢性病管理：通过协同照护减少急性医疗利用与成本 https://news.medxy.ai/ja/chronic-disease-care-high-risk-patients/Medxy AIja2026-11-08T08:55:09-08:00高リスク患者における慢性疾患管理：連携したケアで急性期医療利用と費用を抑える https://news.medxy.ai/vi/chronic-care-management/Medxy AIvi2026-11-08T08:54:45-08:00Quản lý bệnh mạn tính ở bệnh nhân nguy cơ cao: giảm sử dụng chăm sóc cấp tính và chi phí nhờ phối hợp chăm sóc https://news.medxy.ai/chronic-care-management-in-high-risk-patients-reducing-acute-care-utilization-and-costs-through-coordinated-care/Medxy AIen2026-11-08T08:54:26-08:00Chronic Care Management in High-Risk Patients: Reducing Acute Care Utilization and Costs Through Coordinated Care https://news.medxy.ai/zh/activating-cd4-t-cells/Medxy AIzh2026-11-08T08:53:48-08:00激活 CD4+ T 细胞：ALK 阳性 T 细胞淋巴瘤靶向免疫治疗的新前沿 https://news.medxy.ai/ja/cd4-immunotherapy-alk-lymphoma/Medxy AIja2026-11-08T08:53:28-08:00CD4+ T細胞を標的にした新たな免疫療法戦略：ALK陽性T細胞リンパ腫への挑戦 https://news.medxy.ai/vi/cd4-t-cell-immunotherapy-alk-lymphoma/Medxy AIvi2026-11-08T08:53:03-08:00Tế bào T CD4+: Hướng đi mới trong miễn dịch trị liệu nhắm đích cho u lympho tế bào T dương tính với ALK https://news.medxy.ai/harnessing-cd4-t-cells-a-new-frontier-in-targeted-immunotherapy-for-alk-positive-t-cell-lymphoma/Medxy AIen2026-11-08T08:52:43-08:00Harnessing CD4+ T Cells: A New Frontier in Targeted Immunotherapy for ALK-Positive T-Cell Lymphoma https://news.medxy.ai/zh/nsclc-immune-landscape/Medxy AIzh2026-11-08T08:52:04-08:00破解NSCLC免疫图谱：基于致癌基因特异性空间蛋白组学识别预后生态位与治疗靶点 https://news.medxy.ai/ja/nsclc-immune-landscape-2/Medxy AIja2026-11-08T08:51:44-08:00NSCLCの免疫景観を読み解く：オンコジーン別空間プロテオミクスが予後ニッチと治療標的を同定 https://news.medxy.ai/vi/nsclc-spatial-proteomics-immunity/Medxy AIvi2026-11-08T08:51:22-08:00Giải mã bối cảnh miễn dịch trong NSCLC: Spatial proteomics theo từng oncogene xác định các “hốc” tiên lượng và đích điều trị https://news.medxy.ai/decoding-the-immune-landscape-in-nsclc-oncogene-specific-spatial-proteomics-identifies-prognostic-niches-and-therapeutic-targets/Medxy AIen2026-11-08T08:51:03-08:00Decoding the Immune Landscape in NSCLC: Oncogene-Specific Spatial Proteomics Identifies Prognostic Niches and Therapeutic Targets https://news.medxy.ai/bi-allelic-prkcz-loss-of-function-variants-presenting-as-adult-onset-retinitis-pigmentosa-a-case-series-and-functional-characterization/Medxy AIen2026-11-08T08:50:25-08:00Bi-Allelic PRKCZ Loss-of-Function Variants Presenting as Adult-Onset Retinitis Pigmentosa: A Case Series and Functional Characterization https://news.medxy.ai/zh/cavernous-sinus-thrombosis-guidelines/Medxy AIzh2026-11-08T08:49:47-08:00海绵窦血栓形成的早识别与规范处理：如何突破诊断难点并制定治疗策略 https://news.medxy.ai/ja/cavernous-sinus-thrombosis/Medxy AIja2026-11-08T08:49:22-08:00海綿静脈洞血栓症の早期認識と治療：診断の難しさを見極め、最適な治療戦略へ https://news.medxy.ai/vi/cavernous-sinus-thrombosis-2/Medxy AIvi2026-11-08T08:48:56-08:00Nhận diện sớm và quản lý chuẩn hóa tình trạng huyết khối xoang hang: Vượt qua các thách thức trong chẩn đoán và xây dựng chiến lược điều trị https://news.medxy.ai/early-recognition-and-management-of-cavernous-sinus-thrombosis-navigating-diagnostic-challenges-and-therapeutic-strategies/Medxy AIen2026-11-08T08:48:35-08:00Early Recognition and Management of Cavernous Sinus Thrombosis: Navigating Diagnostic Challenges and Therapeutic Strategies https://news.medxy.ai/zh/liver-preservation-techniques/Medxy AIzh2026-11-08T08:47:48-08:00循环死亡后器官捐献肝移植结局优化：机器保存技术的比较评估 https://news.medxy.ai/ja/liver-preservation-techniques-2/Medxy AIja2026-11-08T08:47:28-08:00心停止後臓器提供による肝移植の転帰最適化：機械的保存技術の比較評価 https://news.medxy.ai/vi/optimizing-liver-transplant-outcomes/Medxy AIvi2026-11-08T08:47:02-08:00Tối ưu hóa kết cục trong ghép gan từ hiến tạng sau ngừng tuần hoàn: Đánh giá so sánh các kỹ thuật bảo quản bằng máy https://news.medxy.ai/optimizing-outcomes-in-donation-after-circulatory-death-liver-transplantation-a-comparative-evaluation-of-machine-preservation-techniques/Medxy AIen2026-11-08T08:46:41-08:00Optimizing Outcomes in Donation After Circulatory Death Liver Transplantation: A Comparative Evaluation of Machine Preservation Techniques https://news.medxy.ai/zh/hormone-therapy-cardiovascular-effects/Medxy AIzh2026-11-08T08:46:02-08:00围绝经期口服激素疗法对心血管作用的影响 https://news.medxy.ai/ja/cardiometabolic-status-hormone-therapy-cardiovascular-effects/Medxy AIja2026-11-08T08:45:39-08:00経口閉経期ホルモン療法の心血管作用における心代謝状態の影響 https://news.medxy.ai/vi/hormone-therapy-cardiovascular-effects-cardiometabolic-status/Medxy AIvi2026-11-08T08:45:15-08:00Ảnh hưởng của liệu pháp hormone đường uống trong giai đoạn quanh mãn kinh đối với các kết cục tim mạch https://news.medxy.ai/influence-of-cardiometabolic-status-on-cardiovascular-effects-of-oral-menopausal-hormone-therapy/Medxy AIen2026-11-08T08:44:54-08:00Influence of Cardiometabolic Status on Cardiovascular Effects of Oral Menopausal Hormone Therapy https://news.medxy.ai/zh/hbv-infection-heterogeneity/Medxy AIzh2026-11-08T08:43:56-08:00借助 B-BEST 解读 HBV 感染异质性：来自单细胞病毒-宿主转录组学的新发现 https://news.medxy.ai/ja/b-best-hbv-infection-heterogeneity/Medxy AIja2026-11-08T08:43:33-08:00B-BESTで読み解くHBV感染の不均一性――単一細胞ウイルス—宿主トランスクリプトームが示す新知見 https://news.medxy.ai/vi/decoding-hbv-heterogeneity-b-best/Medxy AIvi2026-11-08T08:43:06-08:00Giải mã tính không đồng nhất của nhiễm HBV bằng B-BEST: Những phát hiện từ transcriptomics đơn bào vi rút–vật chủ https://news.medxy.ai/decoding-hbv-infection-heterogeneity-using-b-best-insights-from-single-cell-viral-host-transcriptomics/Medxy AIen2026-11-08T08:42:46-08:00Decoding HBV Infection Heterogeneity Using B-BEST: Insights from Single-Cell Viral-Host Transcriptomics https://news.medxy.ai/ja/epilepsy-maori-children-new-zealand/Medxy AIja2026-11-08T08:41:45-08:00ニュージーランドにおける異なる民族の小児てんかんの、病因、発作型、症候群、および重症度に関する差異 https://news.medxy.ai/vi/epilepsy-maori-children/Medxy AIvi2026-11-08T08:41:20-08:00Động kinh ở trẻ em New Zealand: khác biệt về căn nguyên, thể bệnh, hội chứng và mức độ nặng giữa trẻ Māori và trẻ không phải Māori-không phải Pasifika https://news.medxy.ai/epilepsy-differences-children/Medxy AIen2026-11-08T08:40:56-08:00Differences in Epilepsy Etiology, Type, Syndrome, and Severity Between Māori and Non-Māori-Non-Pasifika Children With Epilepsy in New Zealand https://news.medxy.ai/zh/adult-onset-type-1-diabetes-subtypes/Medxy AIzh2026-11-08T08:40:04-08:00揭示成人起病1型糖尿病的异质性：临床与代谢亚型为精准诊疗带来新启示 https://news.medxy.ai/ja/adult-onset-type-1-diabetes-subtypes-2/Medxy AIja2026-11-08T08:39:42-08:00成人発症1型糖尿病の多様性を解き明かす：臨床・代謝サブタイプが示す精密医療への新たな示唆 https://news.medxy.ai/vi/adult-onset-t1dm-subtypes/Medxy AIvi2026-11-08T08:39:20-08:00Giải mã sự đa dạng của bệnh tiểu đường loại 1 khởi phát ở người trưởng thành: Những gợi ý mới cho y học chính xác từ các phân nhóm lâm sàng và chuyển hóa https://news.medxy.ai/unraveling-the-heterogeneity-of-adult-onset-type-1-diabetes-clinical-and-metabolic-subtypes-reveal-new-insight-for-precision-care/Medxy AIen2026-11-08T08:38:59-08:00Unraveling the Heterogeneity of Adult-Onset Type 1 Diabetes: Clinical and Metabolic Subtypes Reveal New Insight for Precision Care https://news.medxy.ai/zh/targeting-cardiovascular-inflammation/Medxy AIzh2026-11-08T08:38:14-08:00靶向心血管风险相关炎症：口服 NLRP3 抑制剂 Ruvonoflast 的疗效与安全性 https://news.medxy.ai/ja/inflammation-targeted-cardiovascular-therapy/Medxy AIja2026-11-08T08:37:53-08:00心血管リスクにおける炎症標的治療：経口NLRP3阻害薬Ruvonoflastの有効性と安全性 https://news.medxy.ai/vi/targeting-inflammation-cardiovascular-risk/Medxy AIvi2026-11-08T08:37:29-08:00Nhắm trúng viêm trong nguy cơ tim mạch: Hiệu quả và độ an toàn của thuốc ức chế NLRP3 đường uống Ruvonoflast https://news.medxy.ai/targeting-inflammation-in-cardiovascular-risk-efficacy-and-safety-of-oral-nlrp3-inhibitor-ruvonoflast/Medxy AIen2026-11-08T08:37:10-08:00Targeting Inflammation in Cardiovascular Risk: Efficacy and Safety of Oral NLRP3 Inhibitor Ruvonoflast https://news.medxy.ai/zh/wrestler-metabolic-rate-calibration/Medxy AIzh2026-11-08T08:36:23-08:00能量消耗估算更精准：男性大学摔跤运动员静息代谢率方程的验证与优化 https://news.medxy.ai/ja/energy-expenditure-accuracy/Medxy AIja2026-11-08T08:36:02-08:00エネルギー消費をより正確に捉える：男子大学レスラーにおける安静時代謝率予測式の検証と改良 https://news.medxy.ai/vi/resting-metabolic-rate-validation/Medxy AIvi2026-11-08T08:35:36-08:00Ước tính tiêu hao năng lượng chính xác hơn: Thẩm định và tinh chỉnh các phương trình tỷ lệ chuyển hóa khi nghỉ ngơi ở nam đô vật đại học https://news.medxy.ai/precision-in-energy-expenditure-validating-and-refining-resting-metabolic-rate-equations-for-collegiate-male-wrestlers/Medxy AIen2026-11-08T08:35:17-08:00Precision in Energy Expenditure: Validating and Refining Resting Metabolic Rate Equations for Collegiate Male Wrestlers https://news.medxy.ai/zh/bridging-brain-injury-recovery-knowledge-gap/Medxy AIzh2026-11-08T08:34:34-08:00弥合澳大利亚创伤性脑损伤恢复知识缺口：证据综述及实践启示 https://news.medxy.ai/ja/traumatic-brain-injury-recovery-knowledge-gaps/Medxy AIja2026-11-08T08:34:12-08:00オーストラリアにおける外傷性脳損傷後回復の知識格差をどう埋めるか：エビデンスの統合と実践への示唆 https://news.medxy.ai/vi/brain-injury-recovery-evidence/Medxy AIvi2026-11-08T08:33:34-08:00Thu hẹp khoảng trống kiến thức về hồi phục sau chấn thương sọ não ở người Úc: Tổng hợp bằng chứng và hàm ý thực hành https://news.medxy.ai/bridging-the-knowledge-gaps-in-traumatic-brain-injury-recovery-among-australians-a-synthesis-of-evidence-and-implications-for-practice/Medxy AIen2026-11-08T08:33:12-08:00Bridging the Knowledge Gaps in Traumatic Brain Injury Recovery Among Australians: A Synthesis of Evidence and Implications for Practice https://news.medxy.ai/zh/improving-adult-dental-visits/Medxy AIzh2026-11-08T08:32:04-08:00提升成年人常规牙科就诊：来自RETURN随机对照试验的启示 https://news.medxy.ai/ja/increasing-dental-visits/Medxy AIja2026-11-08T08:31:45-08:00成人の定期歯科受診を高めるには：RETURNランダム化比較試験から得られた知見 https://news.medxy.ai/enhancing-routine-dental-visits-in-adults-insights-from-the-return-randomized-controlled-trial/Medxy AIen2026-11-08T08:31:06-08:00Enhancing Routine Dental Visits in Adults: Insights from the RETURN Randomized Controlled Trial https://news.medxy.ai/zh/perioperative-immunotherapy-bladder-cancer/Medxy AIzh2026-11-08T08:30:27-08:00围手术期度伐利尤单抗联合恩沃利单抗方案为肌层浸润性膀胱癌带来生存获益 https://news.medxy.ai/ja/perioperative-treatment-improves-outcomes/Medxy AIja2026-11-08T08:30:04-08:00筋層浸潤性膀胱癌における周術期デュルバルマブ＋エンホルツマブ ベドチン療法が転帰を改善 https://news.medxy.ai/vi/perioperative-treatment-improves-bladder-cancer-outcomes/Medxy AIvi2026-11-08T08:29:45-08:00Phác đồ Durvalumab kết hợp Envafolimab trong giai đoạn quanh phẫu thuật mang lại lợi ích về sống thêm ở bệnh nhân ung thư bàng quang xâm lấn cơ https://news.medxy.ai/perioperative-durvalumab-and-enfortumab-vedotin-regimens-enhance-outcomes-in-muscle-invasive-bladder-cancer/Medxy AIen2026-11-08T08:29:26-08:00Perioperative Durvalumab and Enfortumab Vedotin Regimens Enhance Outcomes in Muscle-Invasive Bladder Cancer https://news.medxy.ai/zh/submandibular-gland-cancer-neck-dissection/Medxy AIzh2026-11-08T04:21:02-08:00临床无淋巴结转移颌下腺癌是否需要选择性颈清扫术？——对生存获益与手术决策的思考